Search Orphan Drug Designations and Approvals
-
| Generic Name: | a recombinant humanized IgG1 anti-DLL3 monoclonal antibody conjugated to payload YL0010014, a topoisomerase I inhibitor |
|---|---|
| Date Designated: | 01/19/2025 |
| Orphan Designation: | treatment of small cell lung cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Zai Lab (Shanghai) Co., Ltd 4560 Jinke Road, Pudong Building 1, 4/F, Jinchuang Plaza Shanghai 201210 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







